Biomarker-Led Optimization of Successful Surgical Outcomes in Moyamoya
Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · Oct 7, 2024
Trial Information
Current as of July 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
MMD is a condition with narrowing and blockage of major arteries in the brain and people with MMD have a high risk of stroke. Neurosurgical revascularization surgery is usually recommended to provide more blood flow to the brain and hopefully prevent further strokes. The primary goal of this study to improve the understanding of response to neurosurgical treatment and disease improvement or progression by using innovative magnetic resonance imaging (MRI) methods to assess brain blood flow and oxygen use in adults with idiopathic MMD before and after they have surgery.
The study will recrui...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Moyamoya
- • 1. Clinical diagnosis of moyamoya disease as defined by gold-standard catheter angiography and consensus adjudication of imaging and neurological findings
- • 2. Age = 18-60 years
- • 3. Participants for the surgical revascularization aims must be scheduled for clinically indicated indirect surgical revascularization of at least one hemisphere
- • 4. Speak and read English
- • Healthy controls
- • 1. No major medical conditions
- • 2. Age = 18-60 years
- • 3. Speak and read English
- • 4. Able to complete 2 study MRIs and all other study procedures
- Exclusion Criteria:
- • -Both moyamoya and healthy controls
- • 1. History of other major neurological conditions (including but not limited to Parkinson\'s disease, Alzheimer\'s disease, and Multiple Sclerosis) as confirmed by neuroimaging and neurological evaluation (central adjudication committee).
- • 2. History of traumatic brain injury
- • 3. Independent medical condition expected to lead to death within two years.
- • 4. Condition associated with syndromic moyamoya (including but not limited to sickle cell disease, atherosclerosis, neurofibromatosis, Down syndrome).
- • 5. Severe respiratory illness including but not limited to asthma or chronic obstructive pulmonary disease.
- • 7. Contraindication to 3 Tesla MRI 8. Pregnancy
About Vanderbilt University Medical Center
Vanderbilt University Medical Center (VUMC) is a leading academic medical center located in Nashville, Tennessee, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, VUMC integrates cutting-edge scientific inquiry with patient-centered care, supporting a diverse array of studies aimed at enhancing medical knowledge and improving treatment outcomes. With a robust infrastructure and a multidisciplinary team of experts, VUMC fosters collaboration across various fields, ensuring the highest standards of safety and ethical considerations in its research endeavors. Through its dedication to medical discovery and education, VUMC plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Baltimore, Maryland, United States
Nashville, Tennessee, United States
Patients applied
Trial Officials
Manus J Donahue, MBA, PhD
Principal Investigator
Vanderbilt University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported